Parkinson's disease across ethnicities: A nationwide study in New Zealand
- 23 July 2018
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 33 (9) , 1440-1448
Abstract
Background: New Zealand is an ethnically diverse country with a unified national prescribing system. This provides a good framework to use drug‐tracing methodology to establish the prevalence and incidence of Parkinson's disease across different ethnic groups. The objective of this study was to determine the prevalence and incidence of Parkinson's disease in the major ethnic groups in New Zealand.Methods: Information on Parkinson's disease‐related medications was extracted from the national Pharmaceutical Collection of community‐dispensed medications for the period January 1, 2005, to December 31, 2014. Diagnoses for a large subset of individuals were independently determined through national mortality and hospital admissions data sets. We used a Bayesian model, accommodating uncertainty and bias, to estimate the number of people with Parkinson's disease.Results: We found the highest rate of Parkinson's disease in the European ethnic group and the lowest rate in the indigenous Māori. The 2006‐2013 age‐standardized incidence (per 100,000 population per year) was European, 33; Asian, 28; Pasifika, 27; Māori, 20. The 2013 age‐standardized prevalence (per 100,000 population) was European, 223; Asian, 174; Pasifika, 160; Māori, 114.Conclusions: There is a differential occurrence of Parkinson's disease across the major ethnic groups within the New Zealand population, with indigenous Māori showing the lowest incidence. Varying susceptibility profiles, gene‐environment interactions, and inequalities in accessing health care may play a role in the variation in rates of Parkinson's disease in New Zealand. © 2018 International Parkinson and Movement Disorder SocietyKeywords
Funding Information
- Neurological Foundation of New Zealand (1211 PG)
This publication has 29 references indexed in Scilit:
- Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysisBMJ Open, 2013
- The experience and impact of gout in Māori and Pacific people: a prospective observational studyClinical Rheumatology, 2012
- Prediction Model of Parkinson's Disease Based on Antiparkinsonian Drug ClaimsAmerican Journal of Epidemiology, 2011
- Diabetes and Risk of Parkinson’s DiseaseDiabetes Care, 2011
- Ethnic differences in access to prescription medication because of cost in New ZealandJournal of Epidemiology and Community Health, 2010
- Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare BeneficiariesNeuroepidemiology, 2010
- Racial Differences in Parkinson’s Disease Medication Use in the Reasons for Geographic and Racial Differences in Stroke Cohort: A Cross-Sectional StudyNeuroepidemiology, 2009
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- Prevalence of Parkinson's disease in northwestern italy: Comparison of tracer methodology and clinical ascertainment of casesMovement Disorders, 1998
- Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.Journal of Neurology, Neurosurgery & Psychiatry, 1986